View in EDS HTML Full Text PDF Full Text

Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2.

Saved in:
Bibliographic Details
Title: Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2.
Authors: Hilligan KL; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. khilligan@malaghan.org.nz.; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand. khilligan@malaghan.org.nz., Namasivayam S; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Clancy CS; Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA., Baker PJ; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Old SI; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand., Peluf V; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Amaral EP; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Oland SD; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., O'Mard D; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Laux J; Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Cohen M; Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Garza NL; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Lafont BAP; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Johnson RF; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Feng CG; Immunology and Host Defense Group, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2006, Australia.; Centenary Institute, The University of Sydney, Camperdown, NSW, 2050, Australia., Jankovic D; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Lamiable O; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand., Mayer-Barber KD; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Sher A; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. asher@niaid.nih.gov.
Source: Nature communications [Nat Commun] 2023 Dec 12; Vol. 14 (1), pp. 8229. Date of Electronic Publication: 2023 Dec 12.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38086794
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hilligan+KL%22">Hilligan KL</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. khilligan@malaghan.org.nz.; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand. khilligan@malaghan.org.nz.<br /><searchLink fieldCode="AU" term="%22Namasivayam+S%22">Namasivayam S</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Clancy+CS%22">Clancy CS</searchLink>; Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA.<br /><searchLink fieldCode="AU" term="%22Baker+PJ%22">Baker PJ</searchLink>; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Old+SI%22">Old SI</searchLink>; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand.<br /><searchLink fieldCode="AU" term="%22Peluf+V%22">Peluf V</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Amaral+EP%22">Amaral EP</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Oland+SD%22">Oland SD</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22O'Mard+D%22">O'Mard D</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Laux+J%22">Laux J</searchLink>; Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+M%22">Cohen M</searchLink>; Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Garza+NL%22">Garza NL</searchLink>; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Lafont+BAP%22">Lafont BAP</searchLink>; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Johnson+RF%22">Johnson RF</searchLink>; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Feng+CG%22">Feng CG</searchLink>; Immunology and Host Defense Group, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2006, Australia.; Centenary Institute, The University of Sydney, Camperdown, NSW, 2050, Australia.<br /><searchLink fieldCode="AU" term="%22Jankovic+D%22">Jankovic D</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Lamiable+O%22">Lamiable O</searchLink>; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand.<br /><searchLink fieldCode="AU" term="%22Mayer-Barber+KD%22">Mayer-Barber KD</searchLink>; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Sher+A%22">Sher A</searchLink>; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. asher@niaid.nih.gov.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Dec 12; Vol. 14 (1), pp. 8229. <i>Date of Electronic Publication: </i>2023 Dec 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38086794
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-023-43447-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 8229
    Titles:
      – TitleFull: Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hilligan KL
      – PersonEntity:
          Name:
            NameFull: Namasivayam S
      – PersonEntity:
          Name:
            NameFull: Clancy CS
      – PersonEntity:
          Name:
            NameFull: Baker PJ
      – PersonEntity:
          Name:
            NameFull: Old SI
      – PersonEntity:
          Name:
            NameFull: Peluf V
      – PersonEntity:
          Name:
            NameFull: Amaral EP
      – PersonEntity:
          Name:
            NameFull: Oland SD
      – PersonEntity:
          Name:
            NameFull: O'Mard D
      – PersonEntity:
          Name:
            NameFull: Laux J
      – PersonEntity:
          Name:
            NameFull: Cohen M
      – PersonEntity:
          Name:
            NameFull: Garza NL
      – PersonEntity:
          Name:
            NameFull: Lafont BAP
      – PersonEntity:
          Name:
            NameFull: Johnson RF
      – PersonEntity:
          Name:
            NameFull: Feng CG
      – PersonEntity:
          Name:
            NameFull: Jankovic D
      – PersonEntity:
          Name:
            NameFull: Lamiable O
      – PersonEntity:
          Name:
            NameFull: Mayer-Barber KD
      – PersonEntity:
          Name:
            NameFull: Sher A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 12
              Text: 2023 Dec 12
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1